Advertisement|Remove ads.

Bullfrog AI Holdings Inc. (BFRG) shares gained more than 114% in Monday’s pre-market trade after the company announced a deal with a major global pharmaceutical giant.
Bullfrog AI stated that its agreement requires the company to use its bfLEAP program to identify and prioritize novel drug targets in major depressive disorder (MDD). The company stated that this is aimed at accelerating its drug discovery and clinical development programs.
Retail sentiment on Stocktwits around Bullfrog AI trended in the ‘extremely bullish’ territory with message volumes at ‘high’ levels at the time of writing.
Get updates to this developing story directly on Stocktwits.
For updates and corrections, email newsroom[at]stocktwits[dot]com.